331 related articles for article (PubMed ID: 33959609)
1. Chromatin Imbalance as the Vertex Between Fetal Valproate Syndrome and Chromatinopathies.
Parodi C; Di Fede E; Peron A; Viganò I; Grazioli P; Castiglioni S; Finnell RH; Gervasini C; Vignoli A; Massa V
Front Cell Dev Biol; 2021; 9():654467. PubMed ID: 33959609
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and management of individuals with Fetal Valproate Spectrum Disorder; a consensus statement from the European Reference Network for Congenital Malformations and Intellectual Disability.
Clayton-Smith J; Bromley R; Dean J; Journel H; Odent S; Wood A; Williams J; Cuthbert V; Hackett L; Aslam N; Malm H; James G; Westbom L; Day R; Ladusans E; Jackson A; Bruce I; Walker R; Sidhu S; Dyer C; Ashworth J; Hindley D; Diaz GA; Rawson M; Turnpenny P
Orphanet J Rare Dis; 2019 Jul; 14(1):180. PubMed ID: 31324220
[TBL] [Abstract][Full Text] [Related]
3. Neurodevelopmental outcomes in children and adults with Fetal Valproate Spectrum Disorder: A contribution from the ConcePTION project.
Bluett-Duncan M; Astill D; Charbak R; Clayton-Smith J; Cole S; Cook PA; Cozens J; Keely K; Morris J; Mukherjee R; Murphy E; Turnpenny P; Williams J; Wood AG; Yates LM; Bromley RL
Neurotoxicol Teratol; 2023; 100():107292. PubMed ID: 37666366
[TBL] [Abstract][Full Text] [Related]
4. Haploinsufficiency of the Sin3/HDAC corepressor complex member SIN3B causes a syndromic intellectual disability/autism spectrum disorder.
Latypova X; Vincent M; Mollé A; Adebambo OA; Fourgeux C; Khan TN; Caro A; Rosello M; Orellana C; Niyazov D; Lederer D; Deprez M; Capri Y; Kannu P; Tabet AC; Levy J; Aten E; den Hollander N; Splitt M; Walia J; Immken LL; Stankiewicz P; McWalter K; Suchy S; Louie RJ; Bell S; Stevenson RE; Rousseau J; Willem C; Retiere C; Yang XJ; Campeau PM; Martinez F; Rosenfeld JA; Le Caignec C; Küry S; Mercier S; Moradkhani K; Conrad S; Besnard T; Cogné B; Katsanis N; Bézieau S; Poschmann J; Davis EE; Isidor B
Am J Hum Genet; 2021 May; 108(5):929-941. PubMed ID: 33811806
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic disorders: Lessons from the animals-animal models in chromatinopathies.
Di Fede E; Grazioli P; Lettieri A; Parodi C; Castiglioni S; Taci E; Colombo EA; Ancona S; Priori A; Gervasini C; Massa V
Front Cell Dev Biol; 2022; 10():979512. PubMed ID: 36225316
[TBL] [Abstract][Full Text] [Related]
6. Cornelia de Lange Syndrome as Paradigm of Chromatinopathies.
Parenti I; Kaiser FJ
Front Neurosci; 2021; 15():774950. PubMed ID: 34803598
[TBL] [Abstract][Full Text] [Related]
7. The lived experience of young adults with Fetal Valproate Spectrum Disorder, and the perspective of their parents: A qualitative study.
Khanom S; Astill D; Astill N; Cozens J; Mann B; Garratt J; Bromley RL
Epilepsy Behav; 2024 Mar; 152():109680. PubMed ID: 38335859
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of histone deacetylase in utero causes sociability deficits in postnatal mice.
Moldrich RX; Leanage G; She D; Dolan-Evans E; Nelson M; Reza N; Reutens DC
Behav Brain Res; 2013 Nov; 257():253-64. PubMed ID: 24103642
[TBL] [Abstract][Full Text] [Related]
9. Mendelian disorders of the epigenetic machinery: tipping the balance of chromatin states.
Fahrner JA; Bjornsson HT
Annu Rev Genomics Hum Genet; 2014; 15():269-93. PubMed ID: 25184531
[TBL] [Abstract][Full Text] [Related]
10. Expanding the neurological and behavioral phenotype of White-Sutton syndrome: a case report.
Donnarumma B; Riccio MP; Terrone G; Palma M; Strisciuglio P; Scala I
Ital J Pediatr; 2021 Jul; 47(1):148. PubMed ID: 34215294
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic evidence of an Ac/Dc axis by VPA and SAHA.
Lunke S; Maxwell S; Khurana I; K N H; Okabe J; Al-Hasani K; El-Osta A
Clin Epigenetics; 2021 Mar; 13(1):58. PubMed ID: 33743782
[TBL] [Abstract][Full Text] [Related]
12. Prenatal valproate in rodents as a tool to understand the neural underpinnings of social dysfunctions in autism spectrum disorder.
Tartaglione AM; Schiavi S; Calamandrei G; Trezza V
Neuropharmacology; 2019 Nov; 159():107477. PubMed ID: 30639388
[TBL] [Abstract][Full Text] [Related]
13. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism.
Christensen J; Grønborg TK; Sørensen MJ; Schendel D; Parner ET; Pedersen LH; Vestergaard M
JAMA; 2013 Apr; 309(16):1696-703. PubMed ID: 23613074
[TBL] [Abstract][Full Text] [Related]
14. Pentyl-4-yn-VPA, a histone deacetylase inhibitor, ameliorates deficits in social behavior and cognition in a rodent model of autism spectrum disorders.
Foley AG; Cassidy AW; Regan CM
Eur J Pharmacol; 2014 Mar; 727():80-6. PubMed ID: 24486700
[TBL] [Abstract][Full Text] [Related]
15. The facial dysmorphology analysis technology in intellectual disability syndromes related to defects in the histones modifiers.
Pascolini G; Fleischer N; Ferraris A; Majore S; Grammatico P
J Hum Genet; 2019 Aug; 64(8):721-728. PubMed ID: 31086247
[TBL] [Abstract][Full Text] [Related]
16. Prenatal sonographic diagnosis of fetal valproate syndrome: a case report.
Kikuchi N; Ohira S; Asaka R; Tanaka K; Takatsu A; Shiozawa T
J Med Case Rep; 2016 Nov; 10(1):312. PubMed ID: 27809899
[TBL] [Abstract][Full Text] [Related]
17. Perinatal Influences of Valproate on Brain and Behaviour: An Animal Model for Autism.
Ranger P; Ellenbroek BA
Curr Top Behav Neurosci; 2016; 29():363-386. PubMed ID: 26510739
[TBL] [Abstract][Full Text] [Related]
18. SPEN haploinsufficiency causes a neurodevelopmental disorder overlapping proximal 1p36 deletion syndrome with an episignature of X chromosomes in females.
Radio FC; Pang K; Ciolfi A; Levy MA; Hernández-García A; Pedace L; Pantaleoni F; Liu Z; de Boer E; Jackson A; Bruselles A; McConkey H; Stellacci E; Lo Cicero S; Motta M; Carrozzo R; Dentici ML; McWalter K; Desai M; Monaghan KG; Telegrafi A; Philippe C; Vitobello A; Au M; Grand K; Sanchez-Lara PA; Baez J; Lindstrom K; Kulch P; Sebastian J; Madan-Khetarpal S; Roadhouse C; MacKenzie JJ; Monteleone B; Saunders CJ; Jean Cuevas JK; Cross L; Zhou D; Hartley T; Sawyer SL; Monteiro FP; Secches TV; Kok F; Schultz-Rogers LE; Macke EL; Morava E; Klee EW; Kemppainen J; Iascone M; Selicorni A; Tenconi R; Amor DJ; Pais L; Gallacher L; Turnpenny PD; Stals K; Ellard S; Cabet S; Lesca G; Pascal J; Steindl K; Ravid S; Weiss K; Castle AMR; Carter MT; Kalsner L; de Vries BBA; van Bon BW; Wevers MR; Pfundt R; Stegmann APA; Kerr B; Kingston HM; Chandler KE; Sheehan W; Elias AF; Shinde DN; Towne MC; Robin NH; Goodloe D; Vanderver A; Sherbini O; Bluske K; Hagelstrom RT; Zanus C; Faletra F; Musante L; Kurtz-Nelson EC; Earl RK; Anderlid BM; Morin G; van Slegtenhorst M; Diderich KEM; Brooks AS; Gribnau J; Boers RG; Finestra TR; Carter LB; Rauch A; Gasparini P; Boycott KM; Barakat TS; Graham JM; Faivre L; Banka S; Wang T; Eichler EE; Priolo M; Dallapiccola B; Vissers LELM; Sadikovic B; Scott DA; Holder JL; Tartaglia M
Am J Hum Genet; 2021 Mar; 108(3):502-516. PubMed ID: 33596411
[TBL] [Abstract][Full Text] [Related]
19. Dysmorphic features: an important clue to the diagnosis and severity of fetal anticonvulsant syndromes.
Kini U; Adab N; Vinten J; Fryer A; Clayton-Smith J;
Arch Dis Child Fetal Neonatal Ed; 2006 Mar; 91(2):F90-5. PubMed ID: 16239295
[TBL] [Abstract][Full Text] [Related]
20. Clinical Presentation of a Complex Neurodevelopmental Disorder Caused by Mutations in ADNP.
Van Dijck A; Vulto-van Silfhout AT; Cappuyns E; van der Werf IM; Mancini GM; Tzschach A; Bernier R; Gozes I; Eichler EE; Romano C; Lindstrand A; Nordgren A; ; Kvarnung M; Kleefstra T; de Vries BBA; Küry S; Rosenfeld JA; Meuwissen ME; Vandeweyer G; Kooy RF
Biol Psychiatry; 2019 Feb; 85(4):287-297. PubMed ID: 29724491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
